A Phase II Trial of Pictilisib with Chemotherapy in First-Line Squamous NSCLC

被引：0

作者：

Spigel, David ^{[1
]}

Luft, Alexander ^{[2
]}

Vynnychenko, Ihor ^{[3
]}

Fadeeva, Natalia ^{[4
]}

Mark, Zsuzsanna ^{[5
]}

Ponce, Santiago ^{[6
]}

Matrosova, Marina ^{[7
]}

Goldschmidt, Jerome ^{[8
]}

Szima, Barna ^{[9
]}

Saleh, Mansoor ^{[10
]}

Lackner, Mark ^{[11
]}

Gendreau, Steve ^{[11
]}

Bassett, Katia ^{[11
]}

Spoerke, Jill ^{[11
]}

Koeppen, Hartmut ^{[11
]}

Gilbert, Houston ^{[11
]}

Jin, Huan ^{[11
]}

Shankar, Geetha ^{[11
]}

Lin, Wei ^{[11
]}

Denis, Fabrice ^{[12
]}

机构：

[1] Sarah Cannon Res Inst, Nashville, TN USA

[2] Leningrad Reg Clin Hosp, St Petersburg, Russia

[3] Sumy State Univ, Sumy, Ukraine

[4] Chelyabinsk Reg Clin Oncol Dispensary, Chelyabinsk, Russia

[5] Tudogyogyintezet Torokbalint, Torokbalint, Hungary

[6] Hosp Univ 12 Octubre, Madrid, Spain

[7] N Novgorod Reg Oncol Dispensary, Novgorod, Russia

[8] US Oncol Network, Marion, VA USA

[9] Markusovszky Hosp, Szombathely, Hungary

[10] Georgia Canc Specialists, Marietta, GA USA

[11] Genentech Inc, San Francisco, CA 94080 USA

[12] Victor Hugo Clin, Jean Bernard Ctr, Le Mans, France

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

squamous; metastatic; P13K; Placebo-controlled;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MINI30.13

引用

页码：S375 / S375

页数：1

共 50 条

[31] Docetaxel and cisplatin as first-line chemotherapy in advanced NSCLC.
Behera, D
Aggarwal, AN
Gupta, D
Jindal, SK
Sharma, SC
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 705S - 705S
[32] First-Line Nivolumab Plus Ipilimumab versus Chemotherapy in NSCLC
不详
[J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : 465 - 465
[33] Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone as First-Line Therapy for NSCLC
Gadgeel, Shirish
Gandhi, Leena
Borghaei, Hossein
Socinski, Mark A.
Gubens, Matthew A.
Stevenson, James
Sequist, Lecia V.
Yang, James Chih-Hsin
Papadimitrakopoulou, Vassiliki
Bourque, Jennifer
Bachman, Robert D.
Ge, Joy Yang
Im, Ellie
Patnaik, Amita
[J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S428 - S428
[34] Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)
Adenis, A.
Bennouna, J.
Etienne, P. L.
Bogart, E.
Francois, E.
Galais, M. P.
Ben Abdelghani, M.
Michel, P.
Metges, J. P.
Dahan, L.
Conroy, T.
Ghiringhelli, F.
Drouillard, A.
El Hajbi, F.
Samalin, E.
Hiret, S.
Delaine-Clisant, S.
Mariette, C.
Penel, N.
Piessen, G.
Le Deley, M. C.
[J]. EUROPEAN JOURNAL OF CANCER, 2019, 111 : 12 - 20
[35] A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma
Lee, Jeeyun
Im, Young-Hyuck
Cho, Eun Yoon
Hong, Yong Sang
Lee, Hyo Rak
Kim, Hyo Song
Kim, Mi-Jin
Kim, Kwhanmien
Kang, Won Ki
Park, Keunchil
Shim, Young Mog
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (01) : 77 - 84
[36] A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma
Jeeyun Lee
Young-Hyuck Im
Eun Yoon Cho
Yong Sang Hong
Hyo Rak Lee
Hyo Song Kim
Mi-Jin Kim
Kwhanmien Kim
Won Ki Kang
Keunchil Park
Young Mog Shim
[J]. Cancer Chemotherapy and Pharmacology, 2008, 62 : 77 - 84
[37] Gefitinib Superior to Doublet Chemotherapy in Phase III Asian First-Line Advanced NSCLC Study
不详
[J]. ONCOLOGY-NEW YORK, 2008, 22 (11): : 1246 - 1246
[38] A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer
Gelibter, Alain J.
Gamucci, Teresa
Pollera, Camillo F.
Di Costanzo, Francesco
Nuzzo, Carmen
Gabriele, Angela
Signorelli, Carlo
Gasperoni, Silvia
Ferraresi, Virginia
Giannarelli, Diana
Cognetti, Francesco
Zeuli, Massimo
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (09) : 2117 - 2123
[39] Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a Phase II trial
Bajetta, E
Stani, SC
De Candis, D
Bidoli, P
Mariani, L
Zilembo, N
Pozzi, P
Procopio, G
[J]. CANCER, 2000, 89 (04) : 763 - 768
[40] A multicenter phase II trial of tumor treating fields plus chemotherapy for first-line treatment of gastric adenocarcinoma
Li, Jin
Yeo, Winnie
Lam, Ka-On
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)

← 1 2 3 4 5 →